期刊文献+

糖皮质激素受体及其选择性调节剂研究进展 被引量:4

Research progresses in glucocorticoid receptor and selective glucocorticoid receptor modulators
下载PDF
导出
摘要 糖皮质激素(glucocorticoids,GCs)是临床上广泛使用的一类抗炎药物,在体内主要通过糖皮质激素受体(glucocorticoid receptor,GR)发挥生理和药理作用。GR是核受体超家族的成员之一,为配体激活的转录因子,在机体的多种生理和病理活动中扮演重要的角色。随着对GR信号通路的深入研究,寻找针对糖皮质激素受体的新型调节剂,以期将抗炎作用和现有糖皮质激素的副作用相分离,已经成为新药发现的研究热点。本文对近年来GR的分子结构、生物学作用及其选择性调节剂的研究进展作一简要的介绍。 Glucocorticoids (GCs) are widely used as anti-inflammatory therapeutics. Their physiological and pharmacological actions are mainly mediated by glucocorticoid receptor (GR). As a member of the nuclear receptor superfamily, GR is a ligand-activated transcriptional factor and plays important roles in many physiological and pathological processes. With in-depth knowledge on the molecular mechanisms involved in GR- related signal transduction pathways, discovery of novel GR modulators has become one of the focal points in drug development, aiming at increasing efficacies and reducing side effects. In this review, we briefly describe the current understanding of molecular structure, biological functions and selective modulators of GR.
出处 《生命科学》 CSCD 2008年第5期800-806,共7页 Chinese Bulletin of Life Sciences
基金 "973"计划(2004CB518902)
关键词 糖皮质激素 受体 调节剂 glucocorticoids receptor modulators
  • 相关文献

参考文献46

  • 1Pearlman DS, Berger WE, Kerwin E, et al. Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. J Allergy Clin Immunol, 2005, 116(6): 1206-12
  • 2Metselaar JM, van den Berg WB, Holthuysen AE, et al. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type Ⅱ arthritis. Ann Rheum Dis, 2004, 63(4): 348-53
  • 3Teshima M, Kawakami S, Fumoto S, et al. PEGylated liposomes loading palmitoyl prednisolone for prolonged blood concentration of prednisolone. Biol Pharm Bull, 2006, 29 (7): 1436-40
  • 4Hyun E, Bolla M, Steinhoff M, et al. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol, 2004, 143(5): 618-25
  • 5Reichardt HM, Kaestner KH, Tuckermann J, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell, 1998, 93(4): 531-41
  • 6Reichardt HM, Tuckermann JP, Gottlicher M, et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J, 2001, 20(24): 7168- 73
  • 7Stolte EH, van Kemenade BM, Savelkoul HF, et al. Evolution of glucocorticoid receptors with different glucocorticoid sensitivity. J Endocrinol, 2006, 190(1): 17-28
  • 8Yudt MR, Jewell CM, Bienstock R J, et al. Molecular origins for the dominant negative function of human glucocorticoid receptor β. Mol Cell Biol, 2003, 23(12): 4319-30
  • 9Rivers C, Levy A, Hancock J, et al. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab, 1999, 84(11): 4283-6
  • 10McMaster A, Ray DW. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat Clin Pract Endocrinol Metab, 2008, 4(2): 91-101

同被引文献51

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部